---
title: Signatope
date: 2017-08-22T08:46:41Z
modified: 2026-08-12T08:36:58Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/signatope-2/"
type: portfolio
status: publish
excerpt: ""
wpid: 53419
language:
  - English
post_translations:
  - pll_599bef72d33cf
branchen22:
  - R&D Tools
sectors:
  - Diagnostics & R&D Tools
focus_areas:
  - R&D Tools
timestamp: 2026-08-12T08:36:58Z
tags:
  - English
  - pll_599bef72d33cf
  - R&D Tools
  - Diagnostics & R&D Tools
---

## Beschreibungstext

Signatope develops the next generation of protein biomarker assays using a novel type of mass spectrometry-based immunoassays.

SIGNATOPE (SIGNAture epiTOPE) immunoassays are capable of detecting and quantifying protein biomarkers in humans and all pharmacologically relevant model species. Antibodies comprising epitopes of 4 amino acids are the key reagents of SIGNATOPE’s immunoassays. The short epitope allows us to establish quantitative assays for the same protein in different species and for isoforms of protein families. Even immunoassays for notoriously difficult proteins like drug transporters can be established while providing the speed and the sensitivity of an antibody-based method.

## Unternehmenswebsite

https://www.signatope.de/

## Adresse

Signatope GmbH
Markwiesenstr. 55
72770 Reutlingen

## Kontakt

Array

Array

Array